Playback speed
10 seconds
Advanced Breast Cancer: Endocrine Therapy as Preferred Option for HR(+) & Review of CDK4/6 Inhibitors and PIK3CA- Mutant Cohort Trials
394 views
August 1, 2019
Login to view comments.
Click here to Login